slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 22,831-22,860
Pages 885
Rows per page 30
Arc
22,831-22,860 of 26,550
08
The slide uses a process-oriented flow diagram to explain the therapeutic strategy.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Aha Moment1 hit
11
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Key Takeaways1 hit
13
Data presented at EASL 2024. Includes specific patient counts and percentages for Cohorts A1 and A2.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
14
Data presented at EASL 2024. LLOQ = 0.05 IU/mL.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
15
The slide outlines two parallel study arms involving Imdusiran, VTP-300, NA, and Nivolumab.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
16
Data presented at EASL 2024. Includes stacked bar charts for threshold achievement and line chart for mean levels over 72 weeks.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
17
Data presented at EASL 2024. Includes pie charts comparing Group A and Group B across three metrics: time off NA therapy, HBV DNA levels, and HBsAg levels.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
22
Includes references to clinical trials (CheckMate 274, AMBASSADOR, NIAGARA) and drug (Imfinzi).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
23
Clinical trial design flow chart.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
24
The slide outlines a hierarchical testing strategy with alpha-exhaustive recycling and gatekeeping.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
25
The slide presents clinical trial baseline data for two study arms.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
26
Includes a table of clinical trial statistics (events, median EFS, HR, P-value) and a risk table.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
27
Forest plot showing hazard ratios for Imfinzi vs comparator across clinical subgroups.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
28
Includes 'No. of patients at risk' table and statistical summary table.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
29
Forest plot showing hazard ratios with 95% confidence intervals for multiple clinical subgroups.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
30
The table compares safety data across various categories of adverse events, including grade 3/4, serious AEs, and treatment-related outcomes.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
05
Uses a structured layout to categorize problems into three pillars: cost/risk, time, and efficacy.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
BenevolentAI | Investor Presentation Deck | 31 slidesBenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
15
The slide uses a table to demonstrate market validation for early-stage IBD assets.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Market Size1 hit
19
The slide uses a grid layout to present financial KPIs.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Financials1 hit
23
Includes a reference to Eroom's law, which describes the observation that drug discovery is becoming slower and more expensive over time.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
03
Uses a structured table format to link problems to strategic responses.jetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · ProblemLoop · Before After1 hit
04
jetBlue | Investor Event Presentation Deck | 16 slidesjetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Agitate1 hit
06
The slide uses a waterfall-style bridge to show how individual strategic initiatives aggregate to a total financial goal.jetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
07
The slide uses a timeline format to track progress of strategic initiatives from announcement to implementation, culminating in a total EBIT uplift target.jetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Solution1 hit
08
The slide uses four maps to visualize specific route exits or optimizations.jetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Solution1 hit
09
The slide uses a table-like structure to present a chronological progression of strategic initiatives.jetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Solution1 hit
10
The slide uses a structured table-like layout to map considerations to impacts and provides specific fleet delivery/return schedules.jetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Solution1 hit
11
Includes details on Senior Secured Notes, Term Loan, and Senior Convertible Notes.jetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Solution1 hit
12
The slide compares current guidance against previous guidance for key financial metrics including ASMs, Revenue, CASM ex-Fuel, Fuel Price, Interest Expense, and CapEx.jetBlue | Investor Event Presentation Deck | 16 slides · JetBlue
Conference presentation Investor relations Beat · Solution1 hit